Strongbridge Biopharma plc

NASDAQ:SBBP   3:59:56 PM EDT
2.42
-0.02 (-0.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)163.46M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8.31 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$2.52
50-Day MA$2.77
200-Day MA$2.83
See more pivots

Strongbridge Biopharma plc Stock, NASDAQ:SBBP

900 Northbrook Drive, Suite 200, Trevose, Pennsylvania 19053
Phone: +1.610.254.9200
Number of Employees: 72

Description

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Trevose, PA.